These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19261919)

  • 1. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.
    Sanderson L; Dogruel M; Rodgers J; De Koning HP; Thomas SA
    J Pharmacol Exp Ther; 2009 Jun; 329(3):967-77. PubMed ID: 19261919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriers.
    Jeganathan S; Sanderson L; Dogruel M; Rodgers J; Croft S; Thomas SA
    J Pharmacol Exp Ther; 2011 Feb; 336(2):506-15. PubMed ID: 21057057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain.
    Sanderson L; Dogruel M; Rodgers J; Bradley B; Thomas SA
    J Neurochem; 2008 Nov; 107(4):1136-46. PubMed ID: 18823367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
    Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
    Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput decoding of antitrypanosomal drug efficacy and resistance.
    Alsford S; Eckert S; Baker N; Glover L; Sanchez-Flores A; Leung KF; Turner DJ; Field MC; Berriman M; Horn D
    Nature; 2012 Jan; 482(7384):232-6. PubMed ID: 22278056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.
    Yang S; Wenzler T; Miller PN; Wu H; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4064-74. PubMed ID: 24798280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on African Trypanocide Pharmaceutics and Resistance.
    Kasozi KI; MacLeod ET; Ntulume I; Welburn SC
    Front Vet Sci; 2022; 9():828111. PubMed ID: 35356785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter
    Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP
    Elife; 2020 Aug; 9():. PubMed ID: 32762841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors.
    Steverding D
    Exp Parasitol; 2015; 151-152():28-33. PubMed ID: 25662707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.
    Sanderson L; da Silva M; Sekhar GN; Brown RC; Burrell-Saward H; Fidanboylu M; Liu B; Dailey LA; Dreiss CA; Lorenz C; Christie M; Persaud SJ; Yardley V; Croft SL; Valero M; Thomas SA
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009276. PubMed ID: 33857146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for second-stage human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006201. PubMed ID: 23807762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.
    Rodgers J; Stone TW; Barrett MP; Bradley B; Kennedy PG
    Brain; 2009 May; 132(Pt 5):1259-67. PubMed ID: 19339256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for second-stage Human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2010 Aug; (8):CD006201. PubMed ID: 20687080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of trypanocidal drugs used for human African trypanosomosis against Trypanosoma lewisi.
    Dethoua M; Nzoumbou-Boko R; Truc P; Daulouède S; Courtois P; Bucheton B; Cuny G; Semballa S; Vincendeau P
    Parasite; 2013; 20():39. PubMed ID: 24139487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood-brain barrier: evidence for involvement of breast cancer resistance protein.
    Watson CP; Dogruel M; Mihoreanu L; Begley DJ; Weksler BB; Couraud PO; Romero IA; Thomas SA
    Brain Res; 2012 Feb; 1436():111-21. PubMed ID: 22200378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.